$ONC news

The latest ONC stock news: headlines, filings, AI summaries and sentiment for $ONC, updated around the clock.

• BeOne Medicines Raises 2026 Revenue Guidance to $6.9B-$7.0B and Announces Tacabrutide Filing Timeline Seeking Alpha · November 5, 2026, 21:26 UTC
• BeOne Medicines Reports Strong Q3 2026 Results and Raises Full-Year Revenue Guidance Motley Fool · November 5, 2026, 20:58 UTC
• BeOne Medicines Ltd. - 10-Q Filing SEC EDGAR · November 5, 2026, 11:08 UTC
• BeOne Medicines Ltd. - 8-K Filing SEC EDGAR · November 5, 2026, 11:04 UTC
• BeOne Medicines CEO Sells $34.6 Million in Stock but Maintains Large Stake Yahoo Finance · July 23, 2026, 00:03 UTC
• BeOne Medicines CEO Sells $34.6 Million in Stock, Maintains Large Stake Motley Fool · July 22, 2026, 23:43 UTC
• BeOne Medicines Ltd. - 8-K Filing SEC EDGAR · June 26, 2026, 10:06 UTC
• Citizens Upgrades BeOne Medicines (ONC) Following Strong Clinical Data Presentation Yahoo Finance · June 22, 2026, 14:15 UTC
• BeOne Medicines Presents Updated Phase 3 Data for BRUKINSA at EHA Yahoo Finance · June 20, 2026, 18:47 UTC
• Leerink Raises Price Target on BeOne Medicines Following FDA Approval of Sonrotoclax Yahoo Finance · May 22, 2026, 10:59 UTC
• Guggenheim Raises Price Target for BeOne Medicines (ONC) to $420, Maintains Buy Rating Yahoo Finance · May 14, 2026, 20:00 UTC